Ocrelizumab: First Global Approval
Crossref DOI link: https://doi.org/10.1007/s40265-017-0757-6
Published Online: 2017-05-18
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Frampton, James E.
Text and Data Mining valid from 2017-05-18
Version of Record valid from 2017-05-18
Article History
First Online: 18 May 2017
Free to read: This content has been made available to all.